These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33033726)

  • 1. Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses.
    De Ridder T; Ruppin M; Wheeless M; Williams S; Reddell P
    Front Vet Sci; 2020; 7():639. PubMed ID: 33033726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoural Treatment of 18 Cytologically Diagnosed Canine High-Grade Mast Cell Tumours With Tigilanol Tiglate.
    Brown GK; Campbell JE; Jones PD; De Ridder TR; Reddell P; Johannes CM
    Front Vet Sci; 2021; 8():675804. PubMed ID: 34513966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of multiple synchronous canine mast cell tumours using intratumoural tigilanol tiglate.
    Brown GK; Finlay JR; Straw RC; Ziea JY; Leung B; O'Connell K; Thomson MJ; Campbell JE; Jones PD; Reddell P
    Front Vet Sci; 2022; 9():1003165. PubMed ID: 36387404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose Characterization of the Investigational Anticancer Drug Tigilanol Tiglate (EBC-46) in the Local Treatment of Canine Mast Cell Tumors.
    Miller J; Campbell J; Blum A; Reddell P; Gordon V; Schmidt P; Lowden S
    Front Vet Sci; 2019; 6():106. PubMed ID: 31111038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tigilanol Tiglate-Mediated Margins: A Comparison With Surgical Margins in Successful Treatment of Canine Mast Cell Tumours.
    De Ridder T; Reddell P; Jones P; Brown G; Campbell J
    Front Vet Sci; 2021; 8():764800. PubMed ID: 34977208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46).
    Panizza BJ; de Souza P; Cooper A; Roohullah A; Karapetis CS; Lickliter JD
    EBioMedicine; 2019 Dec; 50():433-441. PubMed ID: 31810818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC-46).
    De Ridder TR; Campbell JE; Burke-Schwarz C; Clegg D; Elliot EL; Geller S; Kozak W; Pittenger ST; Pruitt JB; Riehl J; White J; Wiest ML; Johannes CM; Morton J; Jones PD; Schmidt PF; Gordon V; Reddell P
    J Vet Intern Med; 2021 Jan; 35(1):415-429. PubMed ID: 32542733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate.
    Reddell P; De Ridder TR; Morton JM; Jones PD; Campbell JE; Brown G; Johannes CM; Schmidt PF; Gordon V
    J Vet Intern Med; 2021 Jan; 35(1):430-441. PubMed ID: 33438258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful local treatment of a digital canine mast cell tumour with Tigilanol Tiglate].
    Gasser K
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2022 Jun; 50(3):225-231. PubMed ID: 35790169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence-free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglate.
    Jones PD; Campbell JE; Brown G; Johannes CM; Reddell P
    J Vet Intern Med; 2021 Jan; 35(1):451-455. PubMed ID: 33350511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive cutaneous viral pigmented plaques in three Hungarian Vizslas and the response of lesions to topical tigilanol tiglate gel.
    Hansen N; Nicholas N; Pack G; Mackie JT; Shipstone M; Munday JS; Reddell P; Orbell G; Malik R
    Vet Med Sci; 2018 Feb; 4(1):53-62. PubMed ID: 29468081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical synthesis of the therapeutic leads tigilanol tiglate and its analogues.
    Wender PA; Gentry ZO; Fanelli DJ; Luu-Nguyen QH; McAteer OD; Njoo E
    Nat Chem; 2022 Dec; 14(12):1421-1426. PubMed ID: 36192432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimising intratumoral treatment of head and neck squamous cell carcinoma models with the diterpene ester Tigilanol tiglate.
    Barnett CME; Broit N; Yap PY; Cullen JK; Parsons PG; Panizza BJ; Boyle GM
    Invest New Drugs; 2019 Feb; 37(1):1-8. PubMed ID: 29667135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Gene Biomarkers for Tigilanol Tiglate Content in
    Mitu SA; Stewart P; Tran TD; Reddell PW; Cummins SF; Ogbourne SM
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of PKC supports the anticancer activity of tigilanol tiglate and related epoxytiglianes.
    Cullen JK; Boyle GM; Yap PY; Elmlinger S; Simmons JL; Broit N; Johns J; Ferguson B; Maslovskaya LA; Savchenko AI; Mirzayans PM; Porzelle A; Bernhardt PV; Gordon VA; Reddell PW; Pagani A; Appendino G; Parsons PG; Williams CM
    Sci Rep; 2021 Jan; 11(1):207. PubMed ID: 33420238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of equine cutaneous neoplasia in the Pacific Northwest.
    Valentine BA
    J Vet Diagn Invest; 2006 Jan; 18(1):123-6. PubMed ID: 16566271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of intratumoural 5-fluorouracil for the treatment of equine sarcoids.
    Stewart AA; Rush B; Davis E
    Aust Vet J; 2006 Mar; 84(3):101-6. PubMed ID: 16555558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptic Epoxytiglianes from the Kernels of the Blushwood Tree (
    Chianese G; Amin HIM; Maioli C; Reddell P; Parsons P; Cullen J; Johns J; Handoko H; Boyle G; Appendino G; Taglialatela-Scafati O; Gaeta S
    J Nat Prod; 2022 Aug; 85(8):1959-1966. PubMed ID: 35973043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trabectedin: Ecteinascidin 743, Ecteinascidin-743, ET 743, ET-743, NSC 684766.
    Drugs R D; 2006; 7(5):317-28. PubMed ID: 16922593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoplasia in 125 donkeys (Equus asinus): literature review and a survey of five veterinary schools in the United States and Canada.
    Davis CR; Valentine BA; Gordon E; McDonough SP; Schaffer PA; Allen AL; Pesavento P
    J Vet Diagn Invest; 2016 Nov; 28(6):662-670. PubMed ID: 27698162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.